Form 4 holding
Director
Denali Therapeutics Inc.
- Security class
- Common Stock
- Shares / value
- 17,052
- Estimated value
- $347,690
- Report date
- 31 May 2024
- Price
- $20.39
- Ownership
- Direct
Erik Harris - Director at Denali Therapeutics Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- DNLI on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Erik Harris since 03 Jul 2025
Reported holdings for Erik Harris in Denali Therapeutics Inc.
Form 4 holding
Director
Denali Therapeutics Inc.
- Security class
- Stock Option (right to buy)
- Shares / value
- 17,901
- Estimated value
- Report date
- 31 May 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Erik Harris in Denali Therapeutics Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.